185 related articles for article (PubMed ID: 27401257)
1. Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.
Roldan-Deamicis A; Alonso E; Brie B; Braico DA; Balogh GA
Cancer Med; 2016 Sep; 5(9):2427-41. PubMed ID: 27401257
[TBL] [Abstract][Full Text] [Related]
2. CD3Ɛ immune restorative ability induced by Maitake Pro4x in immunosupressed BALBc mice.
Aguilera-Braico DM; Balogh GA
BMC Res Notes; 2022 Sep; 15(1):307. PubMed ID: 36138418
[TBL] [Abstract][Full Text] [Related]
3. Genes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells.
Alonso EN; Orozco M; Eloy Nieto A; Balogh GA
J Med Food; 2013 Jul; 16(7):602-17. PubMed ID: 23875900
[TBL] [Abstract][Full Text] [Related]
4. Antitumoral Effects of D-Fraction from Grifola Frondosa (Maitake) Mushroom in Breast Cancer.
Alonso EN; Ferronato MJ; Gandini NA; Fermento ME; Obiol DJ; López Romero A; Arévalo J; Villegas ME; Facchinetti MM; Curino AC
Nutr Cancer; 2017 Jan; 69(1):29-43. PubMed ID: 27892708
[TBL] [Abstract][Full Text] [Related]
5. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
[TBL] [Abstract][Full Text] [Related]
6. Maitake (D fraction) mushroom extract induces apoptosis in breast cancer cells by BAK-1 gene activation.
Soares R; Meireles M; Rocha A; Pirraco A; Obiol D; Alonso E; Joos G; Balogh G
J Med Food; 2011 Jun; 14(6):563-72. PubMed ID: 21480800
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Cross-Flow Ultrafiltration Fractions from Maitake Medicinal Mushroom, Grifoia frondosa (Agaricomycetes), Reveals Distinct Cytotoxicity in Tumor Cells.
Sari M; Hambitzer R; Lelley JI; Toepler K; Teusch N; Nickisch-Hartfiel A
Int J Med Mushrooms; 2016; 18(8):671-680. PubMed ID: 27910785
[TBL] [Abstract][Full Text] [Related]
8. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients.
Kodama N; Komuta K; Nanba H
J Med Food; 2003; 6(4):371-7. PubMed ID: 14977447
[TBL] [Abstract][Full Text] [Related]
9. Antitumor, Anti-Inflammatory and Antiallergic Effects of
Hetland G; Tangen JM; Mahmood F; Mirlashari MR; Nissen-Meyer LSH; Nentwich I; Therkelsen SP; Tjønnfjord GE; Johnson E
Nutrients; 2020 May; 12(5):. PubMed ID: 32397163
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
[TBL] [Abstract][Full Text] [Related]
11. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice.
Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H
Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects.
Deng G; Lin H; Seidman A; Fornier M; D'Andrea G; Wesa K; Yeung S; Cunningham-Rundles S; Vickers AJ; Cassileth B
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1215-21. PubMed ID: 19253021
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel maitake (Grifola frondosa) protein that activates natural killer and dendritic cells and enhances antitumor immunity in mice.
Tsao YW; Kuan YC; Wang JL; Sheu F
J Agric Food Chem; 2013 Oct; 61(41):9828-38. PubMed ID: 24020458
[TBL] [Abstract][Full Text] [Related]
14. Potential antitumor activity of a low-molecular-weight protein fraction from Grifola frondosa through enhancement of cytokine production.
Kodama N; Mizuno S; Nanba H; Saito N
J Med Food; 2010 Feb; 13(1):20-30. PubMed ID: 20136432
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor.
Masuda Y; Nakayama Y; Tanaka A; Naito K; Konishi M
PLoS One; 2017; 12(3):e0173621. PubMed ID: 28278221
[TBL] [Abstract][Full Text] [Related]
16. Effects of maitake (Grifola frondosa) D-Fraction on the carcinoma angiogenesis.
Matsui K; Kodama N; Nanba H
Cancer Lett; 2001 Oct; 172(2):193-8. PubMed ID: 11566496
[TBL] [Abstract][Full Text] [Related]
17. Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab via Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity.
Masuda Y; Yamashita S; Nakayama Y; Shimizu R; Konishi M
Biol Pharm Bull; 2024; 47(4):840-847. PubMed ID: 38616114
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells.
Alonso EN; Ferronato MJ; Fermento ME; Gandini NA; Romero AL; Guevara JA; Facchinetti MM; Curino AC
Oncotarget; 2018 May; 9(34):23396-23412. PubMed ID: 29805742
[TBL] [Abstract][Full Text] [Related]
19. Maturation of dendritic cells by maitake α-glucan enhances anti-cancer effect of dendritic cell vaccination.
Masuda Y; Nakayama Y; Mukae T; Tanaka A; Naito K; Konishi M
Int Immunopharmacol; 2019 Feb; 67():408-416. PubMed ID: 30586664
[TBL] [Abstract][Full Text] [Related]
20. Potential growth inhibitory effect of maitake D-fraction on canine cancer cells.
Konno S
Vet Ther; 2004; 5(4):263-71. PubMed ID: 15719326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
